Funder
This work was partly supported by the University of Calgary and the Catholic University of Health and Allied Sciences to JS as part of his PhD training
The Calgary Laboratory Services, Calgary, AB.
The University of Calgary Research Seed Grant
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference41 articles.
1. Pitout JD, Laupland KB (2008) Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8:159–166
2. WHO (2017) Prioritization of pathogens to guide discovery, research, and development of new antibiotics for drug resistant bacterial infections, including tuberculosis. The World Health Organization, Geneva http://www.who.int/medicines/areas/rational_use/prioritization-of-pathogens/en/
3. Kaper JB, Nataro JP, Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2:123–140
4. Dale AP, Woodford N (2015) Extra-intestinal pathogenic Escherichia coli (ExPEC): disease, carriage and clones. J Inf Secur 71:615–626
5. Blomberg B, Jureen R, Manji KP, Tamim BS, Mwakagile DS et al (2005) High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania. J Clin Microbiol 43:745–749